Advertisement
News
Advertisement

Boston Scientific's Renegade device gets FDA nod(2)

Mon, 01/31/2011 - 10:38am
Mass High Tech: The Journal of New England Technology

The U.S. Food and Drug Administration has approved Boston Scientific Corp.’s Renegade HI-FLO Fathom Pre-Loaded System, developed to treat uterine fibroids and liver cancer.

The Renegade is designed for interventional radiologists to deliver “diagnostic, embolic and therapeutic materials” to a patient’s circulatory system, the Natick company said in a news release. The device, to be made in eight configurations, combines the company’s Renegade HI-FLO Microcatheter, pre-loaded with its Fathom-16 Steerable Guidewire.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading